MARC details
| 000 -LEADER |
|---|
| fixed length control field |
04590cam a2200217 4500 |
| 001 - CONTROL NUMBER |
|---|
| control field |
9780128005927 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
220107t2016 xxu||||| |||| 00| 0 eng d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9780128005927 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9780128000779 |
| 041 ## - LANGUAGE CODE |
|---|
| Language code of text/sound track or separate title |
eng |
| 100 ## - MAIN ENTRY--PERSONAL NAME |
|---|
| Personal name |
Mydlo, Jack H. |
| 245 #0 - TITLE STATEMENT |
|---|
| Title |
Prostate cancer: science and clinical practice |
| 250 ## - EDITION STATEMENT |
|---|
| Edition statement |
2nd ed. |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) |
|---|
| Place of publication, distribution, etc. |
London : |
| Name of publisher, distributor, etc. |
Academic Press, |
| Date of publication, distribution, etc. |
2016 |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
1 online resource (xix, 639 pages):illustrations (chiefly color) |
| 505 ## - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
Population screening for prostate cancer and early detection -- Inflammation and infection in the etiology of prostate cancer -- Androgen receptor -- Novel research on fusion genes and next-generation sequencing -- Should Gleason score 6 still be called cancer? -- High grade prostatic intraepithelial neoplasia and atypical glands -- Prostate cancer in the elderly -- Prostate cancer and other primary malignancies -- Biopsy prophylaxis, technique, complications, and repeat biopsies -- Total and free PSA, PCA3, PSA density and velocity -- Imaging in localized prostate cancer -- Prostate cancer prevention: strategies and realities -- Prostate-specific antigen screening guidelines -- Cancer of the prostate: incidence in the USA -- International trends in prostate cancer -- Race, ethnicity, marital status, literacy, and prostate cancer outcomes in the united states -- Hereditary prostate cancer -- Neuroendocrine prostate cancer -- Breast and prostate cancers: a comparison of two endocrinologic malignancies -- Heart healthy = prostate healthy and S.A.M. are the ideal ""natural"" recommendations for prostate cancer -- Effects of smoking, alcohol, and exercise on prostate cancer -- Environmental and occupational exposures and prostate cancer -- Level-1 data from the reduce study and the PCPT data -- Decision support for low-risk prostate cancer -- Active surveillance: rationale, patient selection, follow-up, and outcomes -- Preoperative risk assessment -- Is surgery still necessary for prostate cancer? -- Indications for pelvic lymphadenectomy -- The surgical anatomy of the prostate -- Radical retropubic prostatectomy -- Radiation-resistant prostate cancer and salvage prostatectomy -- Postradical prostatectomy incontinence -- Prognostic significance of positive surgical margins and other implications of pathology report -- Open versus robotic prostatectomy -- The technique of robotic nerve-sparing prostatectomy -- Anterior approach to robotic radical prostatectomy -- Posterior approach to robotic-assisted laparoscopic radical prostatectomy -- The technique of robotic nerve sparing prostatectomy: extraperitoneal approach -- Clinical and pathologic staging of prostate cancer -- Management of bladder neck contracture in the prostate cancer survivor -- Reimbursement for prostate cancer treatment -- Fundamentals of radiation treatment for prostate carcinoma -- techniques, radiation biology, and evidence base -- Radiation with hormonal therapy -- Brachytherapy for prostate cancer: an overview -- Intensity modulated radiotherapy and image guidance -- Proton beam therapy -- Radiotherapy after radical prostatectomy: adjuvant versus salvage approach -- Emerging modalities in radiation therapy for prostate cancer -- Management of PSA recurrences after radical prostatectomy -- Salvage therapy for locally recurrent prostate cancer after external beam radiation therapy -- Management of locally advanced (nonmetastatic) prostate cancer -- Androgen deprivation therapy: appropriate patients, timing to initiate ADT, and complications -- Bone health in prostate cancer -- Castration resistant prostate cancer: role of chemotherapy -- Antiandrogen monotherapy in the treatment of prostate cancer -- Sipuleucel-T -- a model for immunotherapy trial development -- Second-line hormonal for castrate-resistant prostate cancer -- Salvage cryoablation of the prostate -- High-intensity focused ultrasound -- Focal therapy for prostate cancer -- Quality of life: impact of prostate cancer and its treatment -- Impact of prostate cancer treatments on sexual health -- Coding and billing for diagnosis and treatment of prostate cancer -- Health policy for prostate cancer: PSA screening as case study -- Legal implications of prostate cancer screening -- New markers for prostate cancer detection and prognosis -- Testosterone therapy in hypogonadal men with prostate cancer." |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) |
|---|
| Topical term or geographic name as entry element |
Prostate |
| 700 ## - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Godec, Ciril J. |
| 856 ## - ELECTRONIC LOCATION AND ACCESS |
|---|
| Uniform Resource Identifier |
<a href="https://go.openathens.net/redirector/nhs?url=https://www.clinicalkey.com/dura/browse/bookChapter/3-s2.0-C2013009891X">https://go.openathens.net/redirector/nhs?url=https://www.clinicalkey.com/dura/browse/bookChapter/3-s2.0-C2013009891X</a> |